- Currently Unavailable
The Heel Support Pad provides bilateral lower limb heel pressure management using a dual-layer viscoelastic foam construction - soft memory foam for adaptive comfort over a stronger visco base for postural support. The 730 x 640mm footprint covers both lower legs simultaneously. Two variants: NCL-P902T1HW (standard, 105mm) and NCL-P906T1HW (with integrated abduction wedge, 255mm). Raised side walls for limb retention. Non-slip VP breathable bi-stretch PU cover. Medium to very high risk. MDR 2017/745 Class I. NICE CG179.
| Specification | Detail |
|---|---|
| NCL-P902T1HW | Standard - 730 x 640 x 105mm |
| NCL-P906T1HW | With integrated abduction wedge - 730 x 640 x 255mm |
| Construction | Dual-layer: soft memory foam upper + stronger visco base |
| Coverage | Bilateral - both lower limbs simultaneously |
| Cover | Bi-stretch waterproof breathable VP polyurethane - non-slip |
| Clinical Risk Level | Medium to very high risk per NICE CG179 |
| Regulatory Status | MDR 2017/745 Class I medical device |
The Heel Support Pad is a Class I medical device under MDR 2017/745. Clinical selection requires occupational therapist or tissue viability assessment per NICE CG179. The variant selected (standard or abduction wedge) must be documented in the care plan with the clinical rationale for each element. Equipment register records and MDR conformity documentation must be maintained for CQC Regulation 12 compliance.
When is the abduction wedge variant (NCL-P906T1HW) indicated over the standard variant?
The abduction wedge variant adds an integrated mid-section between the two lower limb support sections of the pad that holds the legs apart in a controlled abduction position while simultaneously managing heel pressure at both ends. The clinical indication for this variant is when the resident requires both bilateral heel offloading and lower limb abduction as concurrent clinical goals. This occurs in post-hip replacement residents who need abduction maintenance during the recovery period alongside pressure care; in residents with spasticity patterns that cause the legs to adduct toward each other, placing medial knee and ankle pressure injury risk alongside heel risk; and in residents with specific postural conditions where medial leg contact alongside dependent heel loading are both identified risks in the same care plan. The standard variant (NCL-P902T1HW) is appropriate when heel pressure management is the sole clinical objective without a concurrent abduction requirement. The prescribing clinician should assess whether the abduction component of the NCL-P906T1HW is clinically indicated, as its additional height (255mm vs 105mm) increases the limb elevation provided by the pad, which may not always be appropriate for the specific resident's condition.
Why does the Heel Support Pad use two different foam densities in its construction?
The dual-layer design addresses a clinical limitation of single-density foam pads for medium to very high risk users. A soft single-density memory foam pad provides excellent contact conformity and low interface pressure at low loads but compresses significantly under a heavier resident's weight, potentially bottoming out and losing its pressure redistribution function over the repositioning interval. A firm single-density foam maintains its profile under higher loads but provides inadequate contact conformity and generates higher interface pressures at bony prominences for lighter residents. The dual-layer construction solves this by assigning different functions to each layer: the soft memory foam upper layer provides the adaptive contact conformity and low-pressure surface quality at the limb interface regardless of the resident's weight; the firmer viscoelastic base layer provides the structural resistance to prevent the soft upper layer from compressing through to a near-bottomed state, maintaining the effective height and load distribution of the combined construction across the medium to very high weight range the pad is rated for.